Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?

Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus

“…In these analysis, we did not only take account of age, sex and diabetes status, but also adjusted for BMI, as a measure of obesity, and for ALT, as a suitable surrogate of hepatic fat accumulation [33,34]. The level of statistical significance was set at two-sided p-values b 0.05.…”

Higher Fetuin-A Level Is Associated with Coexistence of Elevated Alanine Aminotransferase and the Metabolic Syndrome in the General Population

“…6,7 Elevations of ALT, an indicator of hepatocellular damage, 8 have been shown to be associated with risk of type 2 diabetes mellitus (T2DM) 9 and cardiovascular disease. 10 ALT level is used to define suspected FLD, especially if components of the metabolic syndrome are present and alternative chronic liver diseases can be excluded.…”

Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: A histopathological follow-up study

“…Non-alcoholic hypertransaminasemia, in which viral or other causes of liver disease are excluded, has been used as a surrogate marker for NAFLD [10,11]. The current labelling states that statins should not be used in patients with active liver disease or unexplained persistent aminotransferase elevation.…”